Back to search

Agricultural University of Athens

Πρωτεϊνική μηχανική και μελέτη λυτικών ενζύμων για την καταπολέμηση των ανθεκτικών βακτηρίων

Abstract

dc:description

Multiple Bacterial Resistance which has been recognized as the negative outcome of the constant and repeated application of antibiotics, jeopardize their effects in the field of human health, as this phenomenon takes on dimensions of a global crisis. The discovery of many well-known antibiotics, has always been followed by excessive and irrational use, leading to the appearance bacteria that resist their activity. The fact that, nowadays, infectious deceases caused by microorganisms cannot been cured by antibiotics, makes it a global threat and a major public health issue. In view of multiple resistance, the current project focuses on the cases of multidrug resistant bacteria, which cause dangerous infections in humans across the world, because of this antibiotic resistance mechanisms. The immediate threat to human health is driving researchers into the development of new and innovative antibacterial agents. Lytic enzymes, originated from bacteriophages (endolysins or or enzymes-antibiotics - “Enzybiotics”) hydrolyzing the cell wall of their host, exhibit specificity for the host bacterium at genus level and in some cases down to strain level within the same species. This characteristic makes endolysins a potential alternative or additional compound in modern antibiotics. As the main objective of the current project has been the discovery and evaluation of novel agents capable of alleviating multiple resistance, the first steps aim at the multi-resistant pathogenic bacteria Acinetobacter baumannii and Enterococcus faecium. The study focuses on the discovery of new peptidoglycan hydrolytic enzymes, the Enzybiotics. The use of phage therapy or phage-derived enzymes against bacterial diseases has not been a new strategy. However, the requirement of enzymes with unique physicochemical properties can be fulfilled by functional genomics and by investigating special environmental conditions. The first step was a comparative study using peptidoglycan hydrolases, namely AbLys1 from Acinetobacter phage TZA1 infecting A. baumannii and EfAmi1 from the genome of an Enterococcus faecium prophage region. AbLys1 exhibited substrate preference for bacteria belonging to the species Acinetobacter baumannii, while EfAmi1 showed a wider substrate specificity. The physicochemical and kinetic properties of AbLys1 and EfAmi1 and their antimicrobial activity were investigated against a wide range of both Gram + and Gram - bacteria. Finally, the 3D structures of AbLys1 and EfAmi1 was resolved by X-ray crystallography and studied in detail. The second step included total genomic DNA extraction from marine biofilm, isolated from the industrial zone of Korinthos, Illumina NextSeq500 sequencing and direct search for peptidoglycan hydrolases genes. Bioinformatics analysis of the sequencing data allowed the identification of a glycoside hydrolase, AbLys2, which cloned, expressed and characterized. The enzyme showed substrate preference for Acinetobacter baumannii. The physicochemical and kinetic properties of AbLys2 were investigated, as well as the antimicrobial activity against both Gram + and Gram – bacteria. The second part of the project aimed at finding ways for engineering the substrate specificity and activity of AbLys1. The antimicrobial peptide CLLKKLLKKC (C(LLKK)2C) was fused at the N-terminus of AbLys1. The newly constructed glycoside hydrolase, (art-AbLys1), exhibited expanded and increased activity compared with the wild-type, AbLys1. The enzyme was particular active against Acinetobacter baumannii, ampicillin resistant Enterococcus faecium, Staphylococcus epidermidis (MRSE), Escherichia coli DH5a, compared to AbLys1. Its ability to inhibit bacterial growth is expanded towards Pseudomonas aeruginosa ATCC 27853 and Klebsiella oxytoca. The final step was the development of an encapsulation system for art-AbLys1 using sodium alginate particles (art-AbLys1-AlgPs), as a system of stabilization and/or controlled release. The ability of art-AbLys1-AlgPs to inhibit the formation of bacterial biofilms formed by of Acinetobacter baumanni, Pseudomonas aeruginosa ATCC 27853 and the clinical strain Streptococcus pyogenes was established. Moreover, the results showed that the encapsulation contributed to the improvement of the enzyme stability.

Degree

thesis:*
Grantor dc:publisher
Agricultural University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Premetis, Georgios
  • Πρεμέτης, Γεώργιος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57412

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Premetis, Georgios; Πρεμέτης, Γεώργιος. Πρωτεϊνική μηχανική και μελέτη λυτικών ενζύμων για την καταπολέμηση των ανθεκτικών βακτηρίων. Agricultural University of Athens, 2024. http://hdl.handle.net/10442/hedi/57412